miR-137 Modulates a Tumor Suppressor Network-Inducing Senescence in Pancreatic Cancer Cells.
暂无分享,去创建一个
Frédérick A. Mallette | S. Richard | F. Mallette | Stéphane Richard | Mathieu Neault | Mathieu Neault | Frédérick A Mallette
[1] D Saur,et al. Oncogenic KRAS signalling in pancreatic cancer , 2014, British Journal of Cancer.
[2] Bicheng Zhang,et al. microRNA-137 functions as a tumor suppressor in human non-small cell lung cancer by targeting SLC22A18. , 2015, International journal of biological macromolecules.
[3] Arnold J. Levine,et al. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53 , 1990, Cell.
[4] A. Dejean,et al. Senescence is an endogenous trigger for microRNA-directed transcriptional gene silencing in human cells , 2012, Nature Cell Biology.
[5] Joseph R. Nevins,et al. The E2F transcription factor is a cellular target for the RB protein , 1991, Cell.
[6] Channing J Der,et al. KRAS: feeding pancreatic cancer proliferation. , 2014, Trends in biochemical sciences.
[7] H. Hermeking. The miR-34 family in cancer and apoptosis , 2010, Cell Death and Differentiation.
[8] G. Lou,et al. miR-137 suppresses cell growth in ovarian cancer by targeting AEG-1. , 2013, Biochemical and biophysical research communications.
[9] W. Filipowicz,et al. Tethering of human Ago proteins to mRNA mimics the miRNA-mediated repression of protein synthesis. , 2004, RNA.
[10] J. Nevins,et al. E2F transcription factor is a target for the RB protein and the cyclin A protein. , 1991, Cold Spring Harbor symposia on quantitative biology.
[11] Jason A. Koutcher,et al. Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis , 2005, Nature.
[12] H. Vogel,et al. CHD5 Is a Tumor Suppressor at Human 1p36 , 2007, Cell.
[13] S. Lowe,et al. Probing tumor phenotypes using stable and regulated synthetic microRNA precursors , 2005, Nature Genetics.
[14] Rui Wu,et al. Tumor suppressor p53 meets microRNAs. , 2011, Journal of molecular cell biology.
[15] Y. Choi,et al. Signaling through cyclin D-dependent kinases , 2014, Oncogene.
[16] S. Robinson,et al. Transcription Factor in Melanoma Cell Lines MicroRNA-137 Targets Microphthalmia-Associated , 2008 .
[17] M. Kok,et al. CHD5, a new member of the chromodomain gene family, is preferentially expressed in the nervous system , 2003, Oncogene.
[18] J. Mann,et al. Arrested development and the great escape--the role of cellular senescence in pancreatic cancer. , 2014, The international journal of biochemistry & cell biology.
[19] Hiroshi I. Suzuki,et al. Modulation of microRNA processing by p53 , 2009, Nature.
[20] T. Jiang,et al. miR-137 is frequently down-regulated in glioblastoma and is a negative regulator of Cox-2. , 2012, European journal of cancer.
[21] C. Croce,et al. MicroRNA gene expression deregulation in human breast cancer. , 2005, Cancer research.
[22] R. DePinho,et al. Genetics and biology of pancreatic ductal adenocarcinoma , 2006, Genes & development.
[23] Hao Li,et al. miR‐137 inhibits the proliferation of lung cancer cells by targeting Cdc42 and Cdk6 , 2013, FEBS letters.
[24] Gad Getz,et al. KDM4A Lysine Demethylase Induces Site-Specific Copy Gain and Rereplication of Regions Amplified in Tumors , 2013, Cell.
[25] H. Erdjument-Bromage,et al. Histone demethylation by a family of JmjC domain-containing proteins , 2006, Nature.
[26] X. Chen,et al. miR‐137 targets Cdc42 expression, induces cell cycle G1 arrest and inhibits invasion in colorectal cancer cells , 2011, International journal of cancer.
[27] R. Sullivan,et al. Resistance to BRAF-targeted therapy in melanoma. , 2013, European journal of cancer.
[28] P. Poulikakos,et al. Targeting RAS–ERK signalling in cancer: promises and challenges , 2014, Nature Reviews Drug Discovery.
[29] Qini Gan,et al. PPARγ accelerates cellular senescence by inducing p16INK4α expression in human diploid fibroblasts , 2008, Journal of Cell Science.
[30] N. Mongan,et al. MiR137 is an androgen regulated repressor of an extended network of transcriptional coregulators , 2015, Oncotarget.
[31] P. Pandolfi,et al. PML is a direct p53 target that modulates p53 effector functions. , 2004, Molecular cell.
[32] W. Filipowicz,et al. The long unfinished march towards understanding microRNA-mediated repression , 2015, RNA.
[33] Frédérick A. Mallette,et al. Ablation of PRMT6 reveals a role as a negative transcriptional regulator of the p53 tumor suppressor , 2012, Nucleic acids research.
[34] Christos Sotiriou,et al. MicroRNAs regulate KDM5 histone demethylases in breast cancer cells. , 2016, Molecular bioSystems.
[35] Frédérick A. Mallette,et al. RNF8‐ and RNF168‐dependent degradation of KDM4A/JMJD2A triggers 53BP1 recruitment to DNA damage sites , 2012, The EMBO journal.
[36] Frédérick A. Mallette,et al. Noncanonical NF-κB pathway controls the production of type I interferons in antiviral innate immunity. , 2014, Immunity.
[37] F. McCormick,et al. Cdc42 regulates anchorage-independent growth and is necessary for Ras transformation , 1997, Molecular and cellular biology.
[38] Michael Ruogu Zhang,et al. Dissecting the Unique Role of the Retinoblastoma Tumor Suppressor during Cellular Senescence , 2022 .
[39] S. Lowe,et al. Oncogenic ras Provokes Premature Cell Senescence Associated with Accumulation of p53 and p16INK4a , 1997, Cell.
[40] Pier Paolo Pandolfi,et al. PML regulates p53 acetylation and premature senescence induced by oncogenic Ras , 2000, Nature.
[41] J. Wong,et al. JMJD2A Is a Novel N-CoR-Interacting Protein and Is Involved in Repression of the Human Transcription Factor Achaete Scute-Like Homologue 2 (ASCL2/Hash2) , 2005, Molecular and Cellular Biology.
[42] Jiahuai Han,et al. Molecular and Cellular Pathobiology the Mir-17-92 Cluster of Micrornas Confers Tumorigenicity by Inhibiting Oncogene-induced Senescence , 2022 .
[43] F. Speleman,et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes , 2002, Genome Biology.
[44] Fenghua Wang,et al. Overexpression of paxillin induced by miR-137 suppression promotes tumor progression and metastasis in colorectal cancer , 2012, Carcinogenesis.
[45] S. Lowe,et al. Intrinsic tumour suppression , 2004, Nature.
[46] J. Inazawa,et al. Exploration of tumor-suppressive microRNAs silenced by DNA hypermethylation in oral cancer. , 2008, Cancer research.
[47] G. Peters,et al. Inhibitors of cyclin-dependent kinases induce features of replicative senescence in early passage human diploid fibroblasts , 1998, Current Biology.
[48] Yang Shi,et al. Reversal of Histone Lysine Trimethylation by the JMJD2 Family of Histone Demethylases , 2006, Cell.
[49] D. Esposito,et al. Dragging ras back in the ring. , 2014, Cancer cell.
[50] D. Woods,et al. Senescence of human fibroblasts induced by oncogenic Raf. , 1998, Genes & development.
[51] Young Eun Choi,et al. Charity begins at home: non-coding RNA functions in DNA repair , 2013, Nature Reviews Molecular Cell Biology.
[52] B. Wiedenmann,et al. Tumor suppressor p16INK4a controls oncogenic K‐Ras function in human pancreatic cancer cells , 2012, Cancer science.
[53] J. Otte,et al. Differential regulation of plasminogen activator and inhibitor gene transcription by the tumor suppressor p53. , 1995, Nucleic acids research.
[54] F. Slack,et al. RAS Is Regulated by the let-7 MicroRNA Family , 2005, Cell.
[55] S. Lowe,et al. PML is induced by oncogenic ras and promotes premature senescence. , 2000, Genes & development.
[56] S. Lowe,et al. Premature senescence involving p53 and p16 is activated in response to constitutive MEK/MAPK mitogenic signaling. , 1998, Genes & development.
[57] Reuven Agami,et al. A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors. , 2006, Cell.
[58] J. Shay,et al. A role for both RB and p53 in the regulation of human cellular senescence. , 1991, Experimental cell research.
[59] Samir K. Brahmachari,et al. Posttranscriptional regulation of interleukin-10 expression by hsa-miR-106a , 2009, Proceedings of the National Academy of Sciences.
[60] Prasenjit Dey,et al. Genetics and biology of pancreatic ductal adenocarcinoma , 2006, Genes & development.
[61] Dimitris Kletsas,et al. Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints , 2006, Nature.
[62] M. Barbacid,et al. Tumour biology: Senescence in premalignant tumours , 2005, Nature.
[63] S. Lowe,et al. Tumor suppression by Ink4a-Arf: progress and puzzles. , 2003, Current opinion in genetics & development.
[64] G. Peters,et al. The p16INK4a/CDKN2A tumor suppressor and its relatives. , 1998, Biochimica et biophysica acta.
[65] Charles J. Sherr,et al. Nucleolar Arf sequesters Mdm2 and activates p53 , 1999, Nature Cell Biology.
[66] Frédérick A. Mallette,et al. JMJD2A promotes cellular transformation by blocking cellular senescence through transcriptional repression of the tumor suppressor CHD5. , 2012, Cell reports.
[67] Krishna R. Kalari,et al. FKBP51 affects cancer cell response to chemotherapy by negatively regulating Akt. , 2009, Cancer cell.
[68] Min Wang,et al. microRNA-137 modulates pancreatic cancer cells tumor growth, invasion and sensitivity to chemotherapy. , 2014, International journal of clinical and experimental pathology.
[69] Claudia Petritsch,et al. miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells , 2008 .
[70] M. Byrom,et al. Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis , 2005, Nucleic acids research.
[71] Karl Munger,et al. The papillomavirus E7 proteins. , 2013, Virology.
[72] Frédérick A. Mallette,et al. The DNA damage signaling pathway is a critical mediator of oncogene-induced senescence. , 2007, Genes & development.
[73] H. Stein,et al. Oncogene-induced senescence as an initial barrier in lymphoma development , 2005, Nature.
[74] P. Pearson,et al. Atmospheric carbon dioxide concentrations over the past 60 million years , 2000, Nature.
[75] P. Howley,et al. In vivo ubiquitination and proteasome-mediated degradation of p53(1). , 1996, Cancer research.
[76] D. Peeper,et al. The essence of senescence. , 2010, Genes & development.
[77] C. Burge,et al. Prediction of Mammalian MicroRNA Targets , 2003, Cell.
[78] Simon Tavaré,et al. Autophagy mediates the mitotic senescence transition. , 2009, Genes & development.
[79] S. Robinson,et al. MicroRNA-137 targets microphthalmia-associated transcription factor in melanoma cell lines. , 2008, Cancer research.
[80] J. Shay,et al. BRAFE600-associated senescence-like cell cycle arrest of human naevi , 2005, Nature.